These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23541141)

  • 21. DRESS syndrome in a patient with cystic fibrosis: A case report.
    Gohy S; Froidure A; Lebecque P
    Pediatr Pulmonol; 2017 Apr; 52(4):E18-E21. PubMed ID: 27740720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).
    Silva SA; Figueiredo MM; Carneiro L; Reiss DB; Damásio MA
    Rev Assoc Med Bras (1992); 2016; 62(3):227-30. PubMed ID: 27310545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRESS Syndrome or Hematologic Malignancy?: A Case Report of a 4-Year-Old Boy.
    Besli GE; Yildirim S; Yilmaz K; Yuksel E
    Pediatr Emerg Care; 2017 Jul; 33(7):494-496. PubMed ID: 28665895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation.
    Borroni G; Torti S; Pezzini C; Vassallo C; Rosso R; D'Ospina RM; Tomasini C; Brazzelli V
    G Ital Dermatol Venereol; 2014 Jun; 149(3):291-300. PubMed ID: 24819756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allopurinol Induced DRESS Syndrome.
    Pawar P; Gupta VA; Karnik ND; Vaidya M; Khopkar U
    J Assoc Physicians India; 2014 Nov; 62(11):63-5. PubMed ID: 26281488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver injury in patients with DRESS: A clinical study of 72 cases.
    Lin IC; Yang HC; Strong C; Yang CW; Cho YT; Chen KL; Chu CY
    J Am Acad Dermatol; 2015 Jun; 72(6):984-91. PubMed ID: 25801338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases.
    Skowron F; Bensaid B; Balme B; Depaepe L; Kanitakis J; Nosbaum A; Maucort-Boulch D; Bérard F; D'Incan M; Kardaun SH; Nicolas JF
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2199-205. PubMed ID: 26354734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol-induced DRESS syndrome presented as a cholecystitis-like acute abdomen and aggravated by antibiotics.
    Batista M; Cardoso JC; Oliveira P; Gonçalo M
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30042109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report of drug rash with eosinophilia and systemic symptoms demonstrating human herpesvirus-6 reactivation.
    Ferrero NA; Pearson KC; Zedek DC; Morrell DS
    Pediatr Dermatol; 2013; 30(5):608-13. PubMed ID: 24016284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug reaction with eosinophilia and systemic symptoms (DRESS): A histopathology based analysis.
    Sasidharanpillai S; Govindan A; Riyaz N; Binitha MP; Muhammed K; Khader A; Reena Mariyath OK; Simin M; Subin K
    Indian J Dermatol Venereol Leprol; 2016; 82(1):28-36. PubMed ID: 26728807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in Diagnosis, Management, and Treatment of Allopurinol-Induced DRESS Syndrome: Case Report and Literature Review.
    Thankachen J; Agarwal V
    Am J Ther; 2015; 22(3):e77-83. PubMed ID: 24451301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infectious Mononucleosis and Cholestatic Hepatitis: A Rare Association].
    Salgado C; Garcia AM; Rúbio C; Cunha F
    Acta Med Port; 2017 Dec; 30(12):886-888. PubMed ID: 29364802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestatic hepatitis in a patient with typhoid fever - a case report.
    Ratnayake EC; Shivanthan C; Wijesiriwardena BC
    Ann Clin Microbiol Antimicrob; 2011 Oct; 10():35. PubMed ID: 21982051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interface dermatitis as an indicator of hepatic involvement in drug reaction with eosinophilia and systemic symptoms (DRESS).
    Sasidharanpillai S; Govindan A; Ajithkumar K; Chathoth AT; Khader A; Reena Mariyath OK; Farsha R; Sherin N; David EM
    J Cutan Pathol; 2020 Sep; 47(9):800-808. PubMed ID: 32310304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrent cholestatic course of chronic aggressive hepatitis].
    Erb W; Siede W
    Dtsch Med Wochenschr; 1969 May; 94(22):1145-50. PubMed ID: 5768539
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.
    Ichai P; Laurent-Bellue A; Saliba F; Moreau D; Besch C; Francoz C; Valeyrie-Allanore L; Bretagne SR; Boudon M; Antonini TM; Artru F; Pittau G; Roux O; Azoulay D; Levesque E; Durand F; Guettier C; Samuel D
    Transplantation; 2017 Aug; 101(8):1830-1837. PubMed ID: 28207633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Venous thrombosis, unrecognized complication of DRESS].
    Medhioub Kaaniche F; Allela R; Ben Algia N; Cherif S; Attar M; Frikha I; Mnif M
    Ann Dermatol Venereol; 2017 Feb; 144(2):121-124. PubMed ID: 27522939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shock state: an unrecognized and underestimated presentation of drug reaction with eosinophilia and systemic symptoms.
    Kimmoun A; Dubois E; Perez P; Barbaud A; Levy B
    Shock; 2013 Nov; 40(5):387-91. PubMed ID: 24088996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.